Annexin A5 in Patients With Severe COVID-19 Disease

Conditions

• Coronavirus Infection
• Sepsis

Interventions

• DRUG: recombinant human annexin A5
• DRUG: Placebo

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Collaborators

• [object Object]
• [object Object]